Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii

I. Roca, S. Marti, P. Espinal, P. Martínez, I. Gibert, J. Vila
I. Roca
1Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain
2Institut de Biotecnologia i de Biomedicina i Departament de Genètica i de Microbiologia, Grup de Genètica Molecular Bacteriana, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Marti
1Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Espinal
1Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Martínez
2Institut de Biotecnologia i de Biomedicina i Departament de Genètica i de Microbiologia, Grup de Genètica Molecular Bacteriana, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Gibert
2Institut de Biotecnologia i de Biomedicina i Departament de Genètica i de Microbiologia, Grup de Genètica Molecular Bacteriana, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Vila
1Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jvila@ub.edu
DOI: 10.1128/AAC.00584-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Acinetobacter baumannii has been increasingly associated with hospital-acquired infections, and the presence of multidrug resistance strains is of great concern to clinicians. A. baumannii is thought to possess a great deal of intrinsic resistance to several antimicrobial agents, including chloramphenicol, although the mechanisms involved in such resistance are not well understood. In this work, we have identified a major facilitator superfamily efflux pump present in most A. baumannii strains, displaying strong substrate specificity toward chloramphenicol.

Acinetobacter baumannii is an important opportunistic pathogen often associated with severe nosocomial infections, such as pneumonia, bacteremia, and secondary meningitis, especially in intensive care units. In the last few decades, A. baumannii infections have become a serious health problem due to the emergence of multidrug-resistant (MDR) phenotypes which, therefore, restrain antimicrobial therapy to just a few agents, mainly carbapenems (2, 22).

Antimicrobial resistance can be due to several distinct mechanisms, being that MDR phenotypes are related to the acquisition of genetic elements carrying different resistant determinants or to decreased membrane permeability, together with expression of active efflux pumps (21). To date, the following five efflux systems have been described in A. baumannii: AdeABC and AdeIJK, belonging to the resistance-nodulation-cell division family and conferring resistance to a wide spectrum of antimicrobial agents (3, 9); Tet(A) and Tet(B), from the major facilitator superfamily (MFS), involved in tetracycline and minocycline resistance (10, 11); and AbeM, included within the multidrug and toxic compound extrusion family, providing moderate resistance to several compounds (16).

The recent publication of up to six complete A. baumannii genomes (1, 7, 15, 18), however, accounts for the identification of novel putative efflux systems that may add to those already described in the literature, although experimental proof of their role in antimicrobial resistance is still needed. In this work, we have used homology search-based methods to identify an open reading frame (initially named orf3) encoding a putative efflux pump ortholog present in all fully sequenced A. baumannii strains (GenBank accession no. ABO13543.2). Its deduced amino acid sequence suggests that it consists of 409 residues and contains 12 transmembrane domains (PredictProtein server) (12, 13). It also showed sequence similarity (41% identity and 61% similarity) to the Escherichia coli MdfA protein (GenBank accession no. CAA69997.1), which has been previously described as an MFS efflux pump conferring resistance mainly to ciprofloxacin and chloramphenicol, among others (4). Orf3 was 99% identical among all sequenced Acinetobacter strains and it was also detected by PCR analysis in 82 out of 82 A. baumannii clonally different clinical isolates from our culture collection.

To demonstrate the involvement of Orf3 in MDR, the orf3 gene from A. baumannii strain ATCC 19606 was cloned into the SmaI site of the suicide vector pEX100T (14) and disrupted by the insertion of a Kmr cassette obtained from pUC4K (19). Insertion was at nucleotide position 457 after introducing a BamHI site using a two-step nested PCR mutagenesis. The resulting construct (designated pJV102) was mobilized from the E. coli strain S-17λpir to A. baumannii strain ATCC 19606 Rifr in order to knock out its cognate orf3 gene by allelic replacement. Exconjugants were selected on LB agar plates containing 75 μg/ml rifampin (rifampicin) and 50 μg/ml kanamycin, and cells growing on these plates were further streaked on LB agar containing 50 μg/ml kanamycin and 2% sucrose, to ensure the loss of pJV102. orf3 disruption within the resulting strain, designated JVAB01, was verified by PCR analysis.

Etest susceptibility assays to quinolones, tetracyclines, aminoglycosides, and imipenem (Table 1) showed identical MICs between ATCC 19606 and JVAB01, but a dramatic drop in chloramphenicol resistance was detected for the Orf3 mutant strain (a MIC value of >256 μg/ml for ATCC 19606 compared to 2 μg/ml for JVAB01).

To check that the increased chloramphenicol susceptibility observed for the JVAB01 strain was in fact due to the lack of a functional Orf3 protein, a 1,971-bp PCR fragment containing the A. baumannii ATCC 19606 orf3 gene together with 520 bp upstream from the ATG codon was amplified by PCR and introduced into the EcoRI site of the shuttle vector pWH1266 (5), generating the plasmid pJV103. Electroporation of pJV103 into JVAB01 restored chloramphenicol resistance levels up to 192 μg/ml, indicating that Orf3 was indeed responsible for the chloramphenicol-resistant phenotype. In addition, chloramphenicol resistance in the presence of the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PAβN) was reduced at least eightfold for strain ATCC 19606 and the complemented strain while remaining barely unchanged in the mutant strain (Table 1).

Recent studies indicate that most A. baumannii isolates are intrinsically resistant to chloramphenicol, yet they fail to provide a mechanism responsible for such resistance (6, 8, 17). In a previous work, we analyzed 54 A. baumannii isolates highly resistant to chloramphenicol and demonstrated that they all lacked chloramphenicol acetyltransferase activity (20). Other studies have shown that resistance-nodulation-cell division efflux pumps might participate in chloramphenicol resistance to a certain extent, although they do not account for the high levels found in most isolates (3, 9). In this work, we have shown that orf3 encodes an MFS efflux pump structurally related to the E. coli MdfA protein, although MdfA has been shown to exhibit an extraordinary broad spectrum of drug specificities (4) while Orf3 seems highly specific toward chloramphenicol. We believe this pump is responsible for the intrinsic chloramphenicol resistance described in A. baumannii strains, and therefore we suggest it be named CraA, for chloramphenicol resistance Acinetobacter.

The characterization of intrinsic resistance mechanisms within the genus Acinetobacter favors the potential development of inhibitors to be used in combination with antimicrobial agents in order to increase the available armamentarium against otherwise untreatable MDR strains.

View this table:
  • View inline
  • View popup
TABLE 1.

MICs of antimicrobial agents in the investigated A. baumannii strains

ACKNOWLEDGMENTS

We thank Luis A. Actis for kindly providing plasmids and strains.

This study was supported by the Spanish Ministry of Health (FIS 08/00195) to J.V., by grant 2005SGR-00956 to I.G. and I.R. (Generalitat de Catalunya), and by the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-FEDER, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008). This work was also supported by funding from the European Community (AntiPathoGN contract HEALTH-F3-2008-223101).

FOOTNOTES

    • Received 30 April 2009.
    • Returned for modification 14 June 2009.
    • Accepted 27 June 2009.
  • Copyright © 2009 American Society for Microbiology

REFERENCES

  1. 1.↵
    Adams, M. D., K. Goglin, N. Molyneaux, K. M. Hujer, H. Lavender, J. J. Jamison, I. J. MacDonald, K. M. Martin, T. Russo, A. A. Campagnari, A. M. Hujer, R. A. Bonomo, and S. R. Gill. 2008. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J. Bacteriol.190:8053-8064.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Bergogne-Bérézin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev.9:148-165.
    OpenUrlFREE Full Text
  3. 3.↵
    Damier-Piolle, L., S. Magnet, S. Brémont, T. Lambert, and P. Courvalin. 2008. AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrob. Agents Chemother.52:557-562.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Edgar, R., and E. Bibi. 1997. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J. Bacteriol.179:2274-2280.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Hunger, M., R. Schmucker, V. Kishan, and W. Hillen. 1990. Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids. Gene87:45-51.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Huys, G., K. Bartie, M. Cnockaert, D. T. Hoang Oanh, N. T. Phuong, T. Somsiri, S. Chinabut, F. M. Yusoff, M. Shariff, M. Giacomini, A. Teale, and J. Swings. 2007. Biodiversity of chloramphenicol-resistant mesophilic heterotrophs from Southeast Asian aquaculture environments. Res. Microbiol.158:228-235.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Iacono, M., L. Villa, D. Fortini, R. Bordoni, F. Imperi, R. J. Bonnal, T. Sicheritz-Ponten, G. De Bellis, P. Visca, A. Cassone, and A. Carattoli. 2008. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob. Agents Chemother.52:2616-2625.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Lin, L., B. D. Ling, and X. Z. Li. 2009. Distribution of the multidrug efflux pump genes, adeABC,adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Int. J. Antimicrob. Agents33:27-32.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother.45:3375-3380.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Martí, S., F. Fernández-Cuenca, A. Pascual, A. Ribera, J. Rodríguez-Baño, G. Bou, J. Miguel Cisneros, J. Pachón, L. Martínez-Martínez, and J. Vila. 2006. Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates. Enferm. Infecc. Microbiol. Clin.24:77-80. (In Spanish.)
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Ribera, A., I. Roca, J. Ruiz, I. Gibert, and J. Vila. 2003. Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii. J. Antimicrob. Chemother.52:477-480.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Rost, B. 1996. PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol.266:525-539.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Rost, B., G. Yachdav, and J. Liu. 2004. The PredictProtein server. Nucleic Acids Res.32:W321-W326.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Schweizer, H. P., and T. T. Hoang. 1995. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene158:15-22.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Smith, M. G., T. A. Gianoulis, S. Pukatzki, J. J. Mekalanos, L. N. Ornston, M. Gerstein, and M. Snyder. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev.21:601-614.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Su, X. Z., J. Chen, T. Mizushima, T. Kuroda, and T. Tsuchiya. 2005. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters. Antimicrob. Agents Chemother.49:4362-4364.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Sung, H., S. J. Choi, S. Yoo, and M. N. Kim. 2007. In vitro antimicrobial synergy against imipenem-resistant Acinetobacter baumannii. Korean J. Lab. Med.27:111-117. (In Korean.)
    OpenUrlCrossRefPubMed
  18. 18.↵
    Vallenet, D., P. Nordmann, V. Barbe, L. Poirel, S. Mangenot, E. Bataille, C. Dossat, S. Gas, A. Kreimeyer, P. Lenoble, S. Oztas, J. Poulain, B. Segurens, C. Robert, C. Abergel, J. M. Claverie, D. Raoult, C. Médigue, J. Weissenbach, and S. Cruveiller. 2008. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS ONE3:e1805.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Vieira, J., and J. Messing. 1982. The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene19:259-268.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Vila, J., A. Marcos, F. Marco, S. Abdalla, Y. Vergara, R. Reig, R. Gómez-Lus, and T. Jiménez de Anta. 1993. In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother.37:138-141.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Vila, J., S. Martí, and J. Sánchez-Céspedes. 2007. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother.59:1210-1215.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Vila, J., and J. Pachón. 2008. Therapeutic options for Acinetobacter baumannii infections. Expert Opin. Pharmacother.9:587-599.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii
I. Roca, S. Marti, P. Espinal, P. Martínez, I. Gibert, J. Vila
Antimicrobial Agents and Chemotherapy Aug 2009, 53 (9) 4013-4014; DOI: 10.1128/AAC.00584-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii
I. Roca, S. Marti, P. Espinal, P. Martínez, I. Gibert, J. Vila
Antimicrobial Agents and Chemotherapy Aug 2009, 53 (9) 4013-4014; DOI: 10.1128/AAC.00584-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Acinetobacter baumannii
Anti-Bacterial Agents
Bacterial Proteins
Chloramphenicol Resistance
Drug Resistance, Multiple, Bacterial

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596